Dactinomycin 50-76-0
| Systematic (IUPAC) name: |
2-amino-N,N'- bis[(6S,9R,10S,13R,18aS)- 6,13-diisopropyl- 2,5,9-trimethyl- 1,4,7,11,14-pentaoxohexadecahydro- 1H-pyrrolo[2,1-i] [1,4,7,10,13] oxatetraazacyclohexadecin- 10-yl]- 4,6-dimethyl- 3-oxo- 3H-phenoxazine- 1,9-dicarboxamide |
| Dactinomycin CAS number: |
50-76-0 |
| ATC code: |
L01DA01 |
| PubChem: |
2019 |
| DrugBank: |
APRD00124 |
| Formula: |
C62H86N12O16 |
| Molecular mass: |
1255.42 g/mol |
| Dactinomycin Assay/Purity: |
Typically NLT 98% |
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.